Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1 46Phase 3 16Phase 1/2 6Phase EARLY_PHASE1 5Phase 4 2Phase NA 1

Status

Completed 5Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 4CNS 1Breast 1

Conditions

Ovarian Neoplasms 3Glioblastoma 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × olaparib × Clear all
NCT04614909 2026-05-14

Study of Pamiparib in Newly Diagnosed and rGBM

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
50 enrolled
CNS

Glioblastoma

NCT05320757 2025-06-11

Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients

The University of Hong Kong

Phase EARLY_PHASE1 Completed
20 enrolled
Gynecologic

Endometrial Neoplasms

NCT03378297 2024-10-30

IMPACT

Haukeland University Hospital

Phase EARLY_PHASE1 Completed
26 enrolled
Gynecologic

Ovarian Neoplasms

NCT04041128 2023-03-20

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Completed
14 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02855697 2022-02-22

MOLTO

The Christie NHS Foundation Trust

Phase EARLY_PHASE1 Completed
28 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡